Today: 29 April 2026
Amphenol Corporation stock jumps 8% as CEO set to become chairman; dividend date looms
6 February 2026
1 min read

Amphenol Corporation stock jumps 8% as CEO set to become chairman; dividend date looms

New York, Feb 6, 2026, 12:34 PM EST — Regular session.

Shares of Amphenol Corp jumped nearly 8% to $137.90 in midday trading Friday, far outstripping the broader U.S. market rally. The S&P 500’s SPY ETF climbed roughly 1.6%, while the Nasdaq 100’s QQQ advanced around 1.9%.

The rebound follows a tough stretch for the interconnect maker, whose shares dropped 1.8% Thursday to close at $127.63 amid a broader market selloff. Amphenol remains far off its January 27 peak of $167.04, and Thursday’s volume spiked well above its 50-day average, indicating unsettled investor sentiment.

Governance changes are underway at Amphenol. The board has named President and CEO R. Adam Norwitt as chairman, effective at the annual meeting slated for May. Long-serving chairman Martin H. Loeffler is set to retire from the board. “The decision to appoint Adam … reflects the Board’s confidence,” said lead independent director David P. Falck. Nasdaq

A regulatory filing confirmed Loeffler’s retirement isn’t due to any dispute over the company’s operations, policies, or practices.

For investors, the leadership shuffle adds another factor to consider after a rapid climb followed by a steep drop. Merging the CEO and chair positions might not raise eyebrows for some, but for others, it’s a red flag—especially depending on how the board enforces checks and balances.

An executive trade popped up on the tape as well. According to a Form 4 filing, vice president and corporate controller Michael Ivas exercised options for 25,000 shares on Feb. 4. He also gifted 25,000 shares that same day.

The day’s action is also fueled by tape momentum. As major indexes push higher, investors are snapping up battered industrial tech and data-center-related suppliers. Amphenol typically moves along with that sector when risk appetite picks up.

Yet the rally could reverse fast if the broader upswing stalls. Governance shifts—even those already on the roadmap—often spark fresh scrutiny when a stock is already volatile.

Amphenol plans to pay a $0.25 quarterly dividend on April 14, targeting shareholders recorded by March 23.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Uber stock slides as jury verdict adds legal risk, even with fresh robotaxi push
Previous Story

Uber stock slides as jury verdict adds legal risk, even with fresh robotaxi push

Texas Instruments stock lags chip rally as $7.5B Silicon Labs deal sinks in
Next Story

Texas Instruments stock lags chip rally as $7.5B Silicon Labs deal sinks in

Go toTop